EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Feasibility and performance of cross‐clone Raman calibration models in CHO cultivation

Rafael Machleid, Marek Hoehse, Steffi Scholze, Kleanthis Mazarakis, David Nilsson, Erik Johansson, Christoph Zehe, Johan Trygg, Christian Grimm, Izabella Surowiec iD

Biotechnology Journal · 2024

DOI: 10.1002/biot.202300289 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von Rafael Machleid und 9 weiteren Autor:innen. Beteiligte Einrichtung: Sartorius Stedim Biotech GmbH, Göttingen, Germany. Hauptthemen laut MEDLINE: Lactic Acid, Spectrum Analysis, Raman. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Raman spectroscopy is widely used in monitoring and controlling cell cultivations for biopharmaceutical drug manufacturing. However, its implementation for culture monitoring in the cell line development stage has received little attention. Therefore, the impact of clonal differences, such as productivity and growth, on the prediction accuracy and transferability of Raman calibration models is not yet well described. Raman OPLS models were developed for predicting titer, glucose and lactate using eleven CHO clones from a single cell line. These clones exhibited diverse productivity and growth rates. The calibration models were evaluated for clone‐related biases using clone‐wise linear regression analysis on cross validated predictions. The results revealed that clonal differences did not affect the prediction of glucose and lactate, but titer models showed a significant clone‐related bias, which remained even after applying variable selection methods. The bias was associated with clonal productivity and lead to increased prediction errors when titer models were transferred to cultivations with productivity levels outside the range of their training data. The findings demonstrate the feasibility of Raman‐based monitoring of glucose and lactate in cell line development with high accuracy. However, accurate titer prediction requires careful consideration of clonal characteristics during model development.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Lactic AcidSpectrum Analysis, RamanCricetinaeAnimalsCHO CellsCricetulusCalibrationFeasibility StudiesGlucoseClone Cells

Stichwörter der Autor:innen

CHO cellsbioprocess developmentbioprocess engineeringbioprocess monitoring

Substanzen

Lactic AcidGlucose

Autor:innen und Institutionen

  • Sartorius Stedim Biotech GmbH, Göttingen, Germany.
  • Computational Life Science Cluster (CLiC), Umeå University, Umeå, Sweden.
  • Sartorius Stedim UK Ltd., Epsom, UK.
  • Sartorius Stedim Data Analytics AB, Umeå, Sweden.
  • Sartorius Corporate Research, Ulm, Germany.
  • Sartorius Corporate Research, Umeå, Sweden.

ORCID-Profile: Izabella Surowiec

Zitieren

APA

Machleid, R., Hoehse, M., Scholze, S., Mazarakis, K., Nilsson, D., Johansson, E., Zehe, C., Trygg, J., Grimm, C., & Surowiec, I. (2024). Feasibility and performance of cross‐clone Raman calibration models in CHO cultivation. Biotechnology Journal. https://doi.org/10.1002/biot.202300289

Vancouver

Machleid R, Hoehse M, Scholze S, Mazarakis K, Nilsson D, Johansson E, et al. Feasibility and performance of cross‐clone Raman calibration models in CHO cultivation. Biotechnology Journal. 2024. doi:10.1002/biot.202300289

BibTeX
@article{Machleid2024,
  author = {Machleid, Rafael and Hoehse, Marek and Scholze, Steffi and Mazarakis, Kleanthis and Nilsson, David and Johansson, Erik and Zehe, Christoph and Trygg, Johan and Grimm, Christian and Surowiec, Izabella},
  title = {Feasibility and performance of cross‐clone Raman calibration models in CHO cultivation},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202300289}
}
Kostenlos starten →